32.jpg)
56.jpg)
ROBOKINETICS
RoboKinetics aims to democratise advanced neurological rehabilitation through a patented robotic platform capable of optimising clinical resources and improving treatment efficiency. Our 6‑DOF isokinetic technology, unique in the market, transforms an elite, complex and costly therapy into an accessible, efficient and automated treatment, positioning us to lead a €1 billion robotic rehabilitation market.
Problem: STROKE (CVA)
Isokinetic therapy is the gold standard for upper‑limb rehabilitation, but its high cost, complexity and the need for constant supervision limit it to single–degree‑of‑freedom machines used almost exclusively with elite athletes, leaving the vast neurological‑recovery market (e.g., post‑stroke) largely unserved.
Our Solution:
The core innovation lies in its ability to deliver full 6‑degree‑of‑freedom (6D) motion control (3D translation + 3D rotation), enabling natural, multi‑joint movements that are essential for neurological recovery. Unlike other systems, RoboKinetics adjusts assistance or resistance in real time to the patient’s movement profile and physical condition. Its “programming by demonstration” interface drastically reduces setup time and empowers clinicians.
